Data on the effects of The-Optimal-Lymph-Flow program on lymphedema symptoms in breast cancer survivors

A substantial proportion of more than 50% of breast cancer survivors, who remain undiagnosed with lymphedema, encounter a daily struggle with the presence of multiple and concomitant lymphedema associated symptoms (i.e., lymphedema symptoms). The-Optimal-Lymph-Flow (TOLF) program was developed based...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Mei Rosemary, Du, Xinwen, Li, Yuan, Fu, Lan, Chen, Huaying, Zhang, Xiaoxia, Shui, Yuping, Zhang, Aihua, Feng, Xianqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294092/
https://www.ncbi.nlm.nih.gov/pubmed/37383767
http://dx.doi.org/10.1016/j.dib.2023.109278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294092/
https://www.ncbi.nlm.nih.gov/pubmed/37383767
http://dx.doi.org/10.1016/j.dib.2023.109278

Ejemplares similares